elevidys - Search News

News

Elevidys, Sarepta and FDA

FDA probes death of patient on Sarepta's Elevidys, partner Roche says death unrelated to therapy

The U.S. Food and Drug Administration said on Friday it was investigating the death of an eight-year-old boy who received Sarepta Therapeutics' muscular disorder gene therapy Elevidys. The death occurred on June 7,

· 15h · on MSN

FDA Probes Death of Boy in Brazil on Sarepta’s Elevidys

MIT Technology Review · 1d

The deadly saga of the controversial gene therapy Elevidys

Roche Says CHMP Issued a Negative Opinion on the Conditional Marketing Authorisation for Elevidys

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

EU regulator does not recommend approval of Sarepta's muscle disorder gene therapy

Europe's medicines regulator did not recommend the approval of Sarepta Therapeutics' gene therapy Elevidys for a type of rare ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Elevidys, Sarepta and FDA

Roche Says CHMP Issued a Negative Opinion on the Conditional Marketing Authorisation for Elevidys

EU regulator does not recommend approval of Sarepta's muscle disorder gene therapy

Trending now